Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
China Index MSCI Ishares | MCHI | 1. nov 2024 | 49.48 | +0.47 |
China Jo-Jo Drugstores | CJJD | 1. nov 2024 | 2.33 | -7.91 |
China Liberal Education | CLEU | 1. nov 2024 | 0.23 | -3.85 |
China Natural Resources | CHNR | 1. nov 2024 | 0.68 | -0.90 |
China Pharma | CPHI | 1. nov 2024 | 0.26 | -0.77 |
China Smallcap Index MSCI Ishares | ECNS | 1. nov 2024 | 26.46 | -0.38 |
China SXT Pharmaceuticals | SXTC | 1. nov 2024 | 0.53 | -5.19 |
China Technology ETF Guggenheim | CQQQ | 1. nov 2024 | 40.56 | -1.79 |
China Yuchai International | CYD | 1. nov 2024 | 11.35 | -0.26 |
ChipMOS Technologies ADR | IMOS | 1. nov 2024 | 22.36 | +3.09 |
Chipotle Mexican Grill | CMG | 1. nov 2024 | 58.59 | +5.06 |
Choice Hotels International | CHH | 1. nov 2024 | 138.76 | -0.54 |
ChoiceOne Financial Services | COFS | 1. nov 2024 | 32.98 | -0.57 |
Chord Energy | CHRD | 1. nov 2024 | 123.80 | -1.04 |
Chromadex | CDXC | 1. nov 2024 | 5.86 | +67.91 |
Chromocell Therapeutics | CHRO | 1. nov 2024 | 0.64 | +3.50 |
CHS B Pref 1 | CHSCO | 1. nov 2024 | 26.82 | +0.71 |
CHS B Pref 2 | CHSCN | 1. nov 2024 | 26.16 | +1.08 |
CHS B Pref 4 | CHSCL | 1. nov 2024 | 26.29 | +0.77 |
CHS B Reset Rate Pref 3 | CHSCM | 1. nov 2024 | 25.62 | +1.11 |
CHS Pref | CHSCP | 1. nov 2024 | 29.73 | -0.34 |
Chubb | CB | 1. nov 2024 | 277.41 | -1.78 |
Chunghwa Telecom ADR | CHT | 1. nov 2024 | 37.87 | +0.48 |
Church & Dwight | CHD | 1. nov 2024 | 104.75 | +4.84 |
Churchill Capital IX A | CCIX | 1. nov 2024 | 10.04 | 0.00 |
Churchill Capital IX Unit | CCIXU | 1. nov 2024 | 10.15 | -0.49 |
Churchill Capital Vii | CVIIU | 1. nov 2024 | 9.60 | 0.00 |
Churchill Downs | CHDN | 1. nov 2024 | 138.48 | -1.16 |
Chuys | CHUY | 1. nov 2024 | 37.48 | 0.00 |
CI&T | CINT | 1. nov 2024 | 6.65 | +1.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.